Neoadjuvant chemotherapy response in breast cancer patients with germline BRCA pathogenic variants

被引：0
|
作者：
Mimata, A. [1 ]
Takahashi, Y. [1 ]
Mamori, T. [1 ]
Nakamoto, S. [1 ]
Tsukioki, T. [1 ]
Iwatani, Y. [1 ]
Tanioka, M. [1 ]
Iwatani, T. [1 ]
Shien, T. [1 ]
机构：
[1] Okayama Univ, Okayama, Japan
来源：
BREAST | 2025年 / 80卷
关键词：
D O I：
10.1016/j.breast.2025.104073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P232
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer
    Hadar, Tal
    Mor, Pnina
    Amit, Gefen
    Lieberman, Sari
    Gekhtman, David
    Rabinovitch, Rachel
    Levy-Lahad, Ephrat
    JAMA ONCOLOGY, 2020, 6 (09) : 1460 - 1463
  • [22] Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
    Matteo Lambertini
    Marcello Ceppi
    Anne-Sophie Hamy
    Olivier Caron
    Philip D. Poorvu
    Estela Carrasco
    Albert Grinshpun
    Kevin Punie
    Christine Rousset-Jablonski
    Alberta Ferrari
    Shani Paluch-Shimon
    Angela Toss
    Claire Senechal
    Fabio Puglisi
    Katarzyna Pogoda
    Jose Alejandro Pérez-Fidalgo
    Laura De Marchis
    Riccardo Ponzone
    Luca Livraghi
    Maria Del Pilar Estevez-Diz
    Cynthia Villarreal-Garza
    Maria Vittoria Dieci
    Florian Clatot
    Francois P. Duhoux
    Rossella Graffeo
    Luis Teixeira
    Octavi Córdoba
    Amir Sonnenblick
    Arlindo R. Ferreira
    Ann H. Partridge
    Antonio Di Meglio
    Claire Saule
    Fedro A. Peccatori
    Marco Bruzzone
    Marie Daphne t’Kint de Roodenbeke
    Lieveke Ameye
    Judith Balmaña
    Lucia Del Mastro
    Hatem A. Azim
    npj Breast Cancer, 7
  • [23] Characteristics of Chinese breast cancer patients with double heterozygosity for BRCA1 and BRCA2 germline pathogenic variants
    Wen, Song
    Zhang, Meng
    Chen, Jiuan
    Hu, Li
    Sun, Jie
    Yao, Lu
    Xu, Ye
    Zhang, Juan
    Xie, Yuntao
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 155 - 164
  • [24] Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study
    Lang, Noemie
    Ayme, Aurelie
    Ming, Chang
    Combes, Jean-Damien
    Chappuis, Victor N.
    Friedlaender, Alex
    Vuilleumier, Aurelie
    Sandoval, Jose L.
    Viassolo, Valeria
    Chappuis, Pierre O.
    Labidi-Galy, S. Intidhar
    SWISS MEDICAL WEEKLY, 2023, 153
  • [25] Clinical significance of pathogenic variants in germline BRCA wild type patients at risk for hereditary breast cancer.
    Kuang, Xiaying
    Lin, Ying
    Shao, Nan
    Yu, Liang
    Shan, Zhen
    Chen, Shuyin
    Shi, Xinyi
    Liu, Hao
    Liu, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Evaluation of bone health in breast cancer patients with germline pathogenic variants
    Isiklar, Aysun
    Basaran, Gul
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (05) : 148 - 152
  • [27] Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
    Phillips, Kelly-Anne
    Kotsopoulos, Joanne
    Domchek, Susan
    Chamberlain, James
    Bassett, Julie
    Aeilts, Amber
    Andrulis, Irene
    Buys, Saundra
    Cui, Wanda
    Daly, Mary
    Eisen, Andrea
    Foulkes, William
    Friedlander, Michael
    Gronwald, Jacek
    Hopper, John
    John, Esther
    Karlan, Beth
    Kim, Raymond
    Lubinski, Jan
    Metcalfe, Kelly
    Nathanson, Katherine
    Singer, Christian F.
    Symecko, Heather
    Tung, Nadine
    Narod, Steven
    Terry, Mary Beth
    Milne, Roger
    CANCER RESEARCH, 2024, 84 (09)
  • [28] Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer
    Foulkes, William D.
    Polak, Paz
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2024, 116 (12): : 1871 - 1874
  • [29] Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
    Furlanetto, Jenny
    Moebus, Volker
    Schneeweiss, Andreas
    Rhiem, Kerstin
    Tesch, Hans
    Blohmer, Jens-Uwe
    Luebbe, Kristina
    Untch, Michael
    Salat, Christoph
    Huober, Jens
    Klare, Peter
    Schmutzler, Rita
    Couch, Fergus J.
    Lederer, Bianca
    Gerber, Bernd
    Zahm, Dirk-Michael
    Bauerfeind, Ingo
    Nekljudova, Valentina
    Hanusch, Claus
    Jackisch, Christian
    Link, Theresa
    Hahnen, Eric
    Loibl, Sibylle
    Fasching, Peter A.
    EUROPEAN JOURNAL OF CANCER, 2021, 145 : 44 - 52
  • [30] Hematologic toxicities of chemotherapy in breast and ovarian cancer patients carrying BRCA1/BRCA2 germline pathogenic variants. A single center experience and review of the literature
    Hu-Heimgartner, Ketty
    Lang, Noemie
    Ayme, Aurelie
    Ming, Chang
    Combes, Jean-Damien
    Chappuis, Victor N.
    Vazquez, Carla
    Friedlaender, Alex
    Vuilleumier, Aurelie
    Bodmer, Alexandre
    Viassolo, Valeria
    Sandoval, Jose L.
    Chappuis, Pierre O.
    Labidi-Galy, S. Intidhar
    FAMILIAL CANCER, 2023, 22 (03) : 283 - 289
12345